Presynaptic L-type Ca2+ channels on excessive dopamine release from rat caudate putamen

Physiology and Behavior

Volumn 68, Issue 5, 2000, Pages 641-649

  Okita, Mitsunori ^a   Watanabe, Yasuo ^a   Taya, Koji ^b   Utsumi, Hiroya ^a   Hayashi, Toru ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b BAYER YAKUHIN LTD   (Japan)

Author keywords

Bay K 8644; Caudate putamen; Dopamine; In vivo microdialysis; L type Ca2+channel; Nerve terminal

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 1,4 DIHYDROPYRIDINE DERIVATIVE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CALCIUM CHANNEL; DOPAMINE; FLUPHENAZINE; NIFEDIPINE; NIMODIPINE; SPIPERONE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG EFFECT; HYPERACTIVITY; LOCOMOTION; MALE; MICRODIALYSIS; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT;

EID: 0034025743     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00227-9     Document Type: Article

References (30)

1. ++ antagonists. Hum Psychopharmacol Clin Exp. 3:1998;389-405.
2. 2+ channel modulators as targets for the novel treatment of psychiatric diseases. Hum Psychopharmacol Clin Exp. 3:1999;539-542.
3. 2+ channels in neurons. Dolly J.O. Neurotoxins in Neurochemistry. 1988;162-167 Ellis Horwood Limited, Chichester, UK.
4. Watanabe Y., Li J-W Guo Z. Mechanism on regulation of extracellular amounts of glutamic acid in the cultured brain neuronal and glial cells. Neuroscience. 1:1995;123-128.
5. Hille B. Calcium channels. Hille B. Ionic Channels of Excitable Membranes. 1992;83-114 Sinauer Associates Inc, Sunderland, MA.
6. Miller R.J. Multiple calcium channels and neuronal function. Science. 35:1987;46-52.
7. Wang S.Y., Clague J.R., Langer G.A. Increase in calcium leak channel activity by metabolic inhibition or hydrogen peroxide in rat ventricular myocytes and its inhibition by plication. J Mol Cell Cardiol. 7:1995;211-222.
8. Bezprozvanny I., Scheller R.H., Tsien R.W. Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature. 78:1995;623-628.
9. 2+ channels in mammalian central neurons. Trends Neurosci. 18:1995;89-98.
10. 2+ types coexist to regulate synaptosomal neurotransmitter release. Proc Natl Acad Sci USA. 90:1993;9518-9522.
11. Fossier P., Tauc L., Baux G. Calcium transient and neurotransmitter release at an identified synapse. Trends Neurosci. 22:1999;161-166.
12. + evoked release of dopamine from rat striatal slices. Neurosci Lett. 187:1995;123-126.
13. Moore N.A., Rees G., Sanger G., Awere S. Effect of L-type calcium channel-modulators on stimulant-induced hyperactivity. Neuropharmacology. 32:1993;719-720.
14. Colado M.I., Ormazabal M.J., Alfaro M.J., Martin M.I. Effects of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxy-tryptamine in various brain areas of the rat. J Pharm Pharmacol. 45:1993;220-222.
15. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1982;Academic Press, New York.
16. Cuello A.C., Carson S. Micro-dissection of fresh rat brain tissue slices. Cuello A.C. Brain Micro Dissection Techniques. 1983;37-126 John Wiley & Sons, New York.
17. 2+mobilization of spontaneously hypertensive rats under mild stress. Neurosci Res. 12:1991;346-355.
18. Ben-Ari Y., Kelly J.S. Dopamine evoked inhibition of single cells of the feline putamen and basolateral amygdala. J Physiol. 256:1976;1-21.
19. McKenzie J.S., Shafton A.D., Stewart C.A. Intrastriatal dopaminergic agents, muscarinic simulation, and GABA antagonism compared for rotation responses in rats. Behav Brain Res. 45:1991;163-170.
20. Oertel W.H., Mugnaini E. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci Lett. 47:1984;233-238.
21. Roth R.H., Elsworth J.D. Biochemical pharmacology of midbrain dopamine neurons. Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress:1995;227-243 Raven Press, New York.
22. 2+ modulation of newly synthesized Ser continued GABA-peptides related to the antipsychotic action. Inoue K., Watanabe Y. Calcium Ion Modulators. The New Wave of Psychotropic Drugs:1998;171-183 Harwood Academic Publishers, Netherlands, Singapore.
23. Creese I. Biochemical properties of CNS dopamine receptors. Meltzer H.Y. Psychopharmacology. The Third Generation of Progress:1987;257-264 Raven Press, New York.
24. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev. 18:1993;75-113.
25. 2+ channel activating animal. Folia Pharmacol Jpn. 108:1996;47P-52P.
26. Surmerler D.J., Bargas J., Hemmings H.C. Jr., Naurn A.C., Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron. 14:1995;385-397.
27. Bolger G., Weissman B.A., Skolnick P. The behavioral effects of the calcium agonist BAY K 8644 in the mouse. antagonism by the calcium antagonist nifedipine Naunyn Schmiedebergs Arch Pharmacol. 328:1985;373-377.
28. 2+ levels increased by high-potassium or glutamate in cultured rat cerebellar granule cells. Jpn J Pharmacol. 62:1993;411-414.
29. Bergquist F., Jonason J., Pileblad E., Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra. a microdialysis study in rat J Neurochem. 70:1998;1532-1540.
30. Ishibashi H., Arima J., Rhee J.S., Akaike N. Modulation of high-voltage-activated calcium channels in rat CNS neurons. Inoue K., Watanabe Y. Calcium Ion Modulators. The New Wave of Psychotropic Drugs:1998;1-12 Harwood Academic Publishers, Netherlands, Singapore.